




Geraldine McQuillan, Ph.D., and Deanna Kruszon-Moran, M.S., Division of Health and Nutrition Examination Surveys 
HIV Infection in the United States Household Population 
Aged 18–49 Years: Results from 1999–2006 
NCHS Data Brief
Figure 1. Prevalence of HIV infection among adults by age, sex, and race/ethnicity: 
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1Significantly different from females.
2Significantly different from ages 18–29 years.
3Significantly different from the non-Hispanic white and Mexican-American population.
4Estimate unstable. Based on fewer than 10 HIV-positive persons.  See Appendix table. 
NOTE: Nationally representative sample of the civilian, noninstitutionalized household population. 
SOURCE: CDC/NCHS, National Health and Nutrition Examination Surveys, 1999–2006.
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Data from the National 
Health and Nutrition 
Examination Surveys 
(NHANES) 
►  The prevalence of HIV 
infection among adults 
aged 18–49 years residing in 
households in the United States 
was 0.47% for the period 
1999–2006. 
► Men were more likely to 
be HIV positive than women.  
Race/ethnic disparities in HIV 
infection were also seen. 
Non-Hispanic blacks were more 
likely to be HIV positive than  all 
other race/ethnic groups. 
► Infection with HSV-2 was 
significantly associated with 
HIV infection among the total 
population aged 18–49 years and 
especially so among the non-His-
panic black population. 
► In 1999–2006, nearly 
one-quarter of HIV-positive 
individuals but only 1% of the 
HIV-negative individuals aged 
18–49 years had low CD4 counts 
(a marker of decreased immune 
function). Approximately one-
third of HIV-positive persons 
had healthy immune systems as 
compared with 90% among those 








    
Importance 
Measurement of HIV prevalence in a nationally representative sample of the United States popu-
lation provides an understanding of the background level of infection in the general household 
population aged 18–49 years as well as in demographic subgroups. This information can also be 
used to monitor trends in infection in the household population over time. Other public health 
surveillance systems address the impact of HIV infection among high risk groups including the 
homeless and prisoners that are not included in surveys of the general household population 
(1,2). The combination of information from these surveillance systems with estimates from 
surveys of the general household population provides a more complete picture of the HIV/AIDS 
epidemic in the United States. 
Herpes simplex-virus type 2 (HSV-2) infection is associated with HIV infection; some studies 
have shown that HSV-2 infection doubles the risk of HIV acquisition (3–5). Estimates of the 
prevalence of both HSV-2 and HIV infection can provide further understanding of the risk of 
HIV infection in higher risk subgroups of the general household population. 
CD4 counts (also known as T-helper cells) provide a measure of a person’s immune function.
Among HIV-infected individuals, measurement of CD4 counts is often used to demonstrate how 
well anti-HIV drugs are working. Estimates of this measure in the general population can pro-
vide a picture of health among HIV-infected individuals. 
Keywords: HIV ● CD4 ● seroprevalence ● trends  
Findings 
What is the prevalence of HIV infection among U.S. adults ? 
●		 In 1999–2006, the prevalence of HIV infection among adults aged 18–49 years in the 
civilian noninstitutionalized household population of the United States was 0.47%. 
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The prevalence among men was 0.72% and was significantly higher than the prevalence 
in women 0.22%. 
Adults aged 40–49 years were more likely to be HIV positive compared with those aged 18–29 
years. Approximately 0.61% of adults aged 40–49 years were HIV positive, compared with 0.55% 
of 30–39 year-olds and 0.25% of 18–29 year-olds. 
●		 In 1999–2006, the non-Hispanic black population had an increased prevalence of HIV
    infection compared with other population subgroups. 
The prevalence of HIV infection among the non-Hispanic black population was 2.01%, which 
was significantly higher than among the non-Hispanic white population (0.23%) and the Mexican-
American population (0.30%). 
Among the non-Hispanic black population, the prevalence of HIV infection was higher among men 
(2.64%) than among women (1.49%). 
Is Herpes simplex-virus type 2 (HSV-2) infection associated with HIV infection? 
●		 HIV status was associated with HSV-2 infection, especially among the non-Hispanic black  
population.  
 
Figure 2. HIV prevalence among adults aged 18–49 years, by Herpes simplex-virus 
type 2 (HSV-2) status and race/ethnicity: United States, 1999–2006 






1Significantly different from HSV-2 negative subgroup.
2Estimate unstable. Based on fewer than 10 HIV-positive persons. 
NOTE: Nationally representative sample of the civilian, noninstitutionalized household population adjusted for age. 










(2) HSV-2 infection among persons aged 18–49 years was much higher among non-Hispanic blacks 
(46.6%) as compared with all other race/ethnic groups combined (15.3%) (data not shown). 
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HIV prevalence was higher among all persons aged 18–49 years who were infected with HSV-2 
compared with those who were not infected (1.99% and 0.13%, respectively). 
The higher risk of HIV infection among those HSV-2 positive was especially true for non-Hispanic 
blacks, where the HIV prevalence was 3.69% among HSV-2 positive non-Hispanic blacks. 
How does the immune function of HIV-positive individuals compare with HIV-negative 
individuals? 
●		 The CD4 count (also known as T-helper cells) is a measure of a person’s immune status. 





Figure 3. CD4 count, by HIV status: United States, 1999–2006 
NOTE: Nationally representative sample of the civilian, noninstitutionalized household population aged 18–49 years. 



















Less than 200 
1% 
200–349 
2% In 1999–2006, the majority (90%) of HIV-negative individuals had CD4 counts within the normal 
range (CD4 counts greater than or equal to 500 cells/mm3). 
As expected, many more HIV-positive persons had lower CD4 counts (counts less than 200 
cells/mm3 or between 200 and 349 cells/mm3) (43% combined) as compared with HIV-negative 
persons (3% combined). 
In 1999–2006, 23% of HIV-positive individuals had depressed immune function (CD4 counts less 
than 200 cells/mm3) and only 34.4% of HIV-positive individuals had healthy immune systems 
(CD4 counts greater than or equal to 500 cells/mm3). 3 
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In 1999–2006, the prevalence of HIV infection among U.S. adults aged 18–49 years residing in 
households was 0.47%. In addition, race/ethnic and gender disparities were present. HIV infection 
was higher among non-Hispanic blacks compared with other race/ethnic groups and higher among 
men than women. 
HIV infection was significantly associated with HSV-2 infection. The association was especially 
strong among non-Hispanic blacks where infection with HSV-2 is significantly higher than in all 
other race/ethnic groups. 
Low CD4 counts (less than 200 cells/mm3), a marker for depressed immune function, were much 
more frequent among those who were HIV positive than those HIV negative. Conversely, higher 
CD4 counts (greater than or equal to 500 cells/mm3 ) indicative of normal immune function, were 
much lower among individuals HIV positive as compared with those HIV negative.   
Since the HIV/AIDS epidemic was first recognized in 1981, the Centers for Disease Control and 
Prevention (CDC), in coordination with all states and U.S. dependent areas has conducted AIDS sur-
veillance. As part of the national surveillance program to monitor the HIV/AIDS epidemic, CDC’s 
NHANES survey data provide prevalence estimates from the general household population aged 
18–49 years. Information on risk factors for HIV infection, such as sexual activity and intravenous 
drug use, were not addressed in this analysis, but are collected as part of the NHANES survey. Definitions 
HIV positivity:  Presence of antibody to human immunodeficiency virus (HIV) in blood or urine 
(6). 
CD4 counts:  Enumeration of CD4 T-lymphocytes (also called T-helper cells,  a measure of immune 
function) in blood (7).  Counts greater than or equal to 500 cells/mm3 represents a healthy immune 
system. Counts less than 200 cells/mm3 represent adults with depressed immune function (6). 
HSV-2 positivity:  Presence of antibody to Herpes simplex virus type-2 (HSV-2) in blood (6,8–10). 
Race/ethnicity:  Race/ethnicity was based on self-report and categorized as non-Hispanic white, 
non-Hispanic black, and Mexican American.  Persons not fitting into these categories were classified 
as “other” and included in the total population estimates.  
 
Data source 
National Health and Nutrition Examination Surveys (NHANES) data were used for these analyses.
NHANES is a cross-sectional survey designed to monitor the health and nutritional status of the 
civilian, noninstitutionalized U.S. population (11). The survey consists of interviews conducted in 
participants’ homes, standardized physical examinations conducted in specially outfitted mobile 
examination centers, and laboratory tests utilizing blood and urine specimens provided by 
participants during the physical examination. 
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The NHANES sample is selected through a complex, multistage design that includes selection of 
primary sampling units (counties), household segments within the counties, and finally sample per-
sons from selected households. The sample design includes oversampling in order to obtain reli-
able estimates of health and nutritional measures for population subgroups. In 1999–2006, African 
Americans, Mexican Americans, persons with low income, persons 12–19 years of age, and persons 
60 years and older were oversampled. In 1999, NHANES became a continuous survey, fielded on an 
ongoing basis. Each year of data collection is based on a representative sample covering all ages of 
the civilian, noninstitutionalized population. Public-use data files are released in 2-year cycles. 
Sample weights, which account for the differential probabilities of selection, nonresponse and non-
coverage, are incorporated into the estimation process (12). The standard errors of the percent-
ages were estimated using Taylor Series Linearization in SUDAAN, a method that incorporates the 
sample weights and sample design (13). Ninety-five percent confidence intervals were estimated by 
using the logit transformation (14). 
HIV antibody positive status was measured in examined sample persons aged 18–49 years. To ex-
amine possible predictors of HIV positivity, differences in prevalence were evaluated by examining 
P-values calculated using a univariate t-statistic obtained from a general linear contrast procedure in 
SUDAAN. All differences reported are statistically significant (p < 0.05) unless otherwise indicated. 
When comparing race/ethnic groups, using linear contrasts and when examining the association of 
HSV-2 with HIV status among race/ethnic groups, estimates were age adjusted to the 2000 U.S. 
standard census population using three age groups, 18–29, 30–39, and 40–49 years. This adjustment 
enabled us to compare prevalence estimates between subgroups that differ with respect to their age 
distributions (15). 
All data analyses were performed using the statistical packages SAS version 9.1 (SAS Institute, Cary, 
N.C.) and SUDAAN version 9.0 (Research Triangle Institute, Research Triangle Park, N.C.) (13). 
The relative standard error (RSE), defined as the estimate divided by its standard error, is an indicator 
for statistical reliability. Most estimates in this study are of small magnitude relative to their standard 
errors (i.e., the RSE are large). All estimates whose RSE was greater than a cut point of 40% are des-
ignated with a footnote to indicate that the estimate is statistically unreliable. In addition, estimates 
based on fewer than 10 positive persons are also designated with a footnote to indicate statistical 
unreliability (16).  
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Appendix 
Prevalence of HIV infection from NHANES 1999–2006, by age, gender, and race/ethnicity 
 Number Percent N 95% CI positive positive RSE 
Total1 11928 67 0.47 0.34–0.64 15 
Gender 
Males  5529 47 0.72 a 0.49–1.06 19
 Non-Hispanic
 black 1327 29 2.64
 b 1.88–3.70 17 
All other                                   
race/ethnic groups2 4202 18 0.48 
b 0.26–0.86 29 
Females 6399 20 0.22 a 0.14–0.36 23
 Non-Hispanic
 black 1478 17 1.49 
c 0.91–2.43 24 
All other race/ 
ethnic groups2 4921 3 0.03
 c,3 0.01–0.13 67 
Age1 
18–29 5696 15 0.25 d 0.13–0.48 32 
30–39 3147 23 0.55 0.32–0.94 27 
40–49 3085 29 0.61 d 0.38–0.98 23 
Race/Ethnicity
 Non-Hispanic
 white 4838 10 0.23 
e 0.11–0.48 39
 Non-Hispanic
 black 2805 46 2.01 
e,f 1.50–2.69 14
 Mexican 
    American 3228 7 0.30 
f,3 0.13–0.69 40 
1 Totals differ from the sum for the non-Hispanic white, non-Hispanic black, and Mexican-American 

populations because those in the “other” race/ethnic category are included in the totals.
 
2 Includes non-Hispanic white, Mexican American, and “other” race/ethnicity.
 
3 RSE greater than 40 or number of positive cases less than 10.
 
a p<0.05 for difference between gender.  

b p<0.05 for difference between non-Hispanic black males and males in “All other race/ethnic groups.”
 
c p<0.05 for difference between non-Hispanic black females and females in “All other race/ethnic groups.”
 
d p<0.05 for difference between ages 18–29 and 40–49 years.
 
e p<0.05 for difference between the non-Hispanic black and non-Hispanic white populations.
 
f p<0.05 for difference between the non-Hispanic black and Mexican-American populations.
 
NOTES: CI is confidence interval. RSE is relative standard error. 7 
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